Topics
-
Our Response to the Coronavirus Disease 2019
-
Business Results Announcement for the Fiscal Year Ended March 31, 2020 (See Latest Financial Statements)
-
Sysmex Declaration of a Healthy Company
-
Sysmex Named a “Most Honored Company” for the “2020 All-Japan Executive Team” by Institutional Investor
-
Announcement of Measures to Prevent the Spread of COVID-19
-
Sysmex Obtains First Marketing Approval in Japan for the Novel Coronavirus Nucleic Acid Detection Kits (RT-PCR Method)
Press Releases
- Information about Litigation against Sysmex Corporation and its Subsidiary (PDF：105KB)
- Sysmex Donates ¥30 Million to Kobe City Support Fund for Medical Professionals to Support COVID-19 Countermeasures (PDF：107KB)
- The City of Kobe, Sysmex and SRL Configure and Begin Operating a PCR Testing System for COVID-19 within the Kobe Biomedical Innovation Cluster (PDF：105KB)
- Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2020 (PDF：234KB)
- Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2020 (PDF：46KB)
